Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway

Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway

An intermittent fasting (IF) regimen has been shown to protect against metabolic dysfunction-associated steatohepatitis (MASH). However, the precise mechanism remains unclear. Here, we explored how IF reduced hepatic lipid accumulation, inflammation, and fibrosis in mice with MASH. The mice were fed...

Full description

Bibliographic Details
Main Authors: Kyung Eun Kim, Hyun Joo Shin, Yeajin Ju, Youngae Jung, Hyeong Seok An, So Jeong Lee, Eun Ae Jeong, Jaewoong Lee, Geum-Sook Hwang, Gu Seob Roh
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Nutrients
Subjects:
intermittent fasting
autophagy
lysosome
non-alcoholic steatohepatitis
Online Access:https://www.mdpi.com/2072-6643/15/21/4574

Internet

https://www.mdpi.com/2072-6643/15/21/4574

Similar Items